US pharma major Bristol Myers Squibb (NYSE: BMY) is set to lay off another 516 employees at its New Jersey, USA site, ...

US investment firm Deerfield Management has closed its latest fund with $600 million in commitments to support advances in ...

Some $45 million has been raised in a Series B financing round by Nuevocor, an IND-stage biotech developing therapies for ...

USA-based rare disease drug developer PTC Therapeutics (Nasdaq: PTCT) on Monday announced results from the Phase II PIVOT-HD ...

UK pharma major AstraZeneca (LSE: AZN) today revealed that its Calquence (acalabrutinib) in combination with bendamustine and ...

The US Food and Drug Administration (FDA) accepted Novo Nordisk’s New Drug Application (NDA) submission for an ...

Benchtop cell factory company Astraveus has entered into a strategic partnership with The Netherlands Center for the Clinical ...

Portugal-based Hovione and Firstgene Life Sciences, a portfolio company of the Swiss incubator Xlife Sciences (SIX: XLS), ...

Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO). Founded in France and ...

German biotech BioNTech (Nasdaq: BNTX) saw its shares dip 3.4% to $101.44 today, after it reported financial results for the ...

US subsidiary and Iceland-based Alvotech (Nasdaq: ALVO) today announced that the US Food and Drug Administration (FDA) has ...

T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...